Director/PDMR Shareholding

September 07, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 13 August 2018, it purchased 469,866 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at 3.60p per Ordinary Share (the “Purchase”). Following the purchase, Vulpes has a total direct and indirect interest in 58,729,297 equivalent to 19.89% of Proteome Sciences' total issued share capital.

Back to News